Litcius/Paper detail

The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020

Xiaoxia Liang, Qian Yang, Pan Wu, Changliang He, Lizi Yin, Funeng Xu, Zhongqiong Yin, Guizhou Yue, Yuanfeng Zou, Lixia Li, Xu Song, Cheng Lv, Wei Zhang, Bo Jing

2021Bioorganic Chemistry47 citationsDOI

Topics & Concepts

Tyrosine kinaseCancer therapyTyrosine-kinase inhibitorChemistryPharmacologyCancer researchTyrosineCancerKinaseMedicineSignal transductionBiochemistryInternal medicineQuinazolinone synthesis and applicationsHER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020 | Litcius